Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how the body processes and gets rid of NVA237 in people
who have impaired kidney function compared to people whose kidney function is normal.